BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 123795
Published online Jan 14, 2027. doi: 10.3748/wjg.123795
Figure 8
Figure 8 Proposed mechanism underlying the protective effects of melatonin against pathological angiogenesis in cirrhotic portal hypertension. Melatonin disrupts the interaction between POMK and VEGFR-2, resulting in reduced VEGFR-2 phosphorylation and attenuation of downstream PLC-γ/ERK1/2 signaling activation. This inhibition suppresses VEGF-induced endothelial cell proliferation and angiogenesis, thereby contributing to the improvement of splanchnic hyperdynamic circulation in cirrhotic portal hypertension. HUVEC: Human umbilical vein endothelial cell.


Write to the Help Desk